CLOUGH CAPITAL PARTNERS L P - Q3 2019 holdings

$1.21 Billion is the total value of CLOUGH CAPITAL PARTNERS L P's 99 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 0.0% .

 Value Shares↓ Weighting
CHCT  COMMUNITY HEALTHCARE TR INC$8,211,000
+13.1%
184,3000.0%0.68%
-4.6%
MASI  MASIMO CORP$1,071,000
-0.1%
7,2000.0%0.09%
-15.2%
HIX  WESTERN ASSET HIGH INCM FD I$237,000
-3.3%
34,9000.0%0.02%
-16.7%
EIM  EATON VANCE MUN BD FD$225,000
+4.2%
17,3870.0%0.02%
-9.5%
AFT  APOLLO SR FLOATING RATE FD I$163,000
-0.6%
10,9980.0%0.01%
-18.8%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

  • Charles I. Clough, Jr. #1
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BK OF AMERICA CORP37Q3 20235.0%
MICROSOFT CORP35Q3 20235.5%
CITIGROUP INC33Q2 20215.8%
JPMORGAN CHASE & CO33Q3 20233.2%
D R HORTON INC32Q3 20233.2%
TRANSDIGM GROUP INC32Q3 20233.9%
VERTEX PHARMACEUTICALS INC32Q2 20231.6%
JAZZ PHARMACEUTICALS PLC32Q3 20231.6%
VERACYTE INC31Q2 20230.8%
LENNAR CORP30Q1 20222.7%

View CLOUGH CAPITAL PARTNERS L P's complete holdings history.

Latest significant ownerships (13-D/G)
CLOUGH CAPITAL PARTNERS L P Q3 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Checkmate Pharmaceuticals, Inc.February 14, 20221,137,7645.3%
Correvio Pharma Corp.Sold outFebruary 24, 202000.0%
Cardiome Pharma CorpApril 27, 20182,058,7635.9%
CARVANA CO.April 27, 20181,072,0503.6%
HEALTHWAYS, INCJanuary 12, 20161,850,2895.1%
Kura Oncology, Inc.January 12, 20161,076,3335.0%
VERACYTE, INC.January 12, 20161,049,0543.8%
Solar Senior Capital Ltd.February 11, 2013325,0932.8%
MAGAL SECURITY SYSTEMS LTDSold outMarch 23, 201100.0%
BIOSPHERE MEDICAL INCSold outFebruary 10, 201100.0%

View CLOUGH CAPITAL PARTNERS L P's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-15
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-16
13F-HR2022-05-16
13F-HR2022-02-14

View CLOUGH CAPITAL PARTNERS L P's complete filings history.

Compare quarters

Export CLOUGH CAPITAL PARTNERS L P's holdings